The Latest Breaking News from Carl Hansen

AbCellera Biologics Q1 Earnings Call Highlights

AbCellera Biologics (NASDAQ:ABCL) said its first quarter of 2026 was marked by progress in its internal drug pipeline, including interim Phase 1 data for its lead program, ABCL635, and continued preparation for multiple clinical catalysts expected over the next two years. President and CEO Dr. Carl

MarketBeat · May 11

Exclusive: Your delivery robot will now offer the blind real-time, on-the-ground eyes around sidewalk hazards

Coco Robotics is partnering with BlindSquare, the world’s most popular GPS app for the blind, to turn data from delivery robots into spoken alerts.

Fortune · Apr 20

The Contents of This London Boutique Hotel Are Being Auctioned Off — So You Can Get a Deal on Designer Floor Lamps, Custom Sofas, and 'Sculptural' Wardrobes

I considered not sharing the intel, but there's no gatekeeping at Livingetc

Livingetc · Apr 10

Canada needs to invest more money into science innovation to help prevent the next global crisis

Canada has lagged behind its peer nations in innovation for decades. Currently, Canada is ranked 11th out of the 16 similarly developed countries assessed. While our “C” grade is a moderate improvement over our previous “D” grade, innovation still remains a barrier to high-quality job creation and economic prosperity in…

The Conversation · Jun 28, 2022